You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).

Figure INF-17 Trends in HCV seroprevalence among injecting drug users, 1997 to 2004

Notes:

seroprevalence studies (SP)

diagnostic testing (DT)

unlinked anonymous testing (UAT)

Data filter | inffig17-en.xml